Femur Head Necrosis
16
2
2
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
19%
3 trials in Phase 3/4
38%
3 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (16)
Modifications of the Subchondral Bone in Aseptic Osteonecrosis of the Femoral Head
Observational Study to Evaluate Long-Term Outcome in Hip Arthroplasty
Bupivacaine Liposome Plus Bupivacaine or Ropivacaine for Pericapsular Nerve Group Block in Hip Arthroplasty (PENG)
Efficiency and Safety of Navigation Aids in Total Hip Arthroplasty With Direct Anterior Approach
Difference in Return to Sports Activity After Hip Arthroplasty by THR or Resurfacing
GWAS Identified Susceptibility Loci for Glucocorticoid-induced FHN in the Chinese Population
Prospective Clinical 5-year Follow-up of the LINK® SP-CL® Hip Prosthesis Stem
Anesthesia Depth's Influence on Postoperative Delirium
Excia T Cementless EBRA Study
Clinical and Radiological Results of Total Hip Arthroplasty Using a Ceramic Friction Pair
Observational Study Evaluating Outcomes of Hip Arthroplasty Using Tornier Dual Mobility Acetabular Cup
Investigation of the Femoral Shortening Osteotomy in the Developmental Dislocation of the Hip (FSODDH)
Prophylaxis of Deep Vein Thrombosis Following Total Hip Arthroplasty
Benefit of Orthopedic Navigation in the ARThroplasty of the Hip
Effectiveness of Two Types of Treatment in Restoring Muscle After Hip or Knee Surgery
Examine the Possible Association of Hepatic CYP3A Activity and the Susceptibility to Femur Head Necrosis